Incidence of Cerebral Cavernous Malformation-Related Epilepsy in Children: A Single Center Survey

Masahiro Narita1, Yosuke Miyairi2, Mitsuo Motobayashi1

  • 1Pediatric Neurology, Nagano Children's Hospital, Azumino, JPN.

Cureus
|May 30, 2023
PubMed

Insights

Pediatric cerebral cavernous malformations (CCMs) show a 35.7% prevalence of epilepsy, with an incidence of 11.3% per patient-year. Seizures from intra-CCM hemorrhage indicate a higher risk in children.

Area of Science:

  • Neurology
  • Pediatrics
  • Vascular Malformations

Background:

  • Cerebral cavernous malformations (CCMs) are rare cerebrovascular developmental abnormalities.
  • Epilepsy is a common comorbidity in CCM patients, but incidence in pure pediatric cohorts is underreported.

Purpose of the Study:

  • To determine the incidence of epilepsy in a pediatric population with CCMs.
  • To identify risk factors for CCM-related epilepsy in children.

Main Methods:

  • Retrospective analysis of 14 pediatric CCM cases diagnosed between 2001 and 2020.
  • Patients were categorized into epilepsy and non-epilepsy groups for comparison.

Main Results:

  • The prevalence of CCM-related epilepsy was 35.7%, with an incidence of 11.3% per patient-year.
  • Seizures due to intra-CCM hemorrhage as a primary symptom were significantly more frequent in the epilepsy group (p=0.01).
  • No significant differences were found in other clinical characteristics or sequelae between groups.

Conclusions:

  • CCM-related epilepsy incidence in children (11.3% per patient-year) is higher than reported in mixed adult/pediatric populations.
  • Intra-CCM hemorrhage presenting as initial seizures is a risk factor for epilepsy in pediatric CCMs.
  • Further research on large pediatric cohorts is needed to understand CCM-related epilepsy pathophysiology and higher pediatric incidence.
Abstract